Innovation in pharma

Health 03-11-2020

Innovation and patients at the core of EU orphan drugs law review

The EU's Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines which treat an estimated 30 million patients with rare diseases across the EU.
Health 06-07-2020

Reviewing orphan drugs law: A tough equation

Download PDF  

The Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines which treat patients with rare diseases. Around 246,000 people suffer from such diseases across the EU, The European Commission is expected...